On the other hand, alterations in genes such as the anaplastic lymphoma kinase (ALK) gene, BRAF gene, Kirsten rat sarcoma viral oncogene (KRAS), mesenchymal epithelial transition (MET) gene, and ROS1 are frequently observed in patients with NSCLC-AC [65]. This evidence concerns the gene ALK and non-small cell lung carcinoma.